Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Clump

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Oral Oncology|September 2, 2014
Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking historyKara S Davis, John A Vargo, Robert L Ferris, et al.
Practical Radiation Oncology|November 5, 2025
A Case for Caution in a New Era of Managing Patients with Locally Advanced Non-Small Cell Lung Cancer: Fatal Bronchial-Esophageal Fistula After Neoadjuvant Chemo-Immunotherapy Followed by Definitive Chemoradiation TherapyKaitlyn Heintzelman, John C Knoth, Casey Mozingo, et al.
Seminars in Radiation Oncology|March 23, 2016
Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell CarcinomaKimmen Quan, Karen M Xu, Yongqian Zhang, et al.
American Journal of Clinical Oncology|April 11, 2017
Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland MalignanciesBrian J Gebhardt, James P Ohr, Robert L Ferris, et al.
Oncoimmunology|May 31, 2019
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRTMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, William E Gooding, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2018
Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic CancerPhilip Sutera, David A Clump, Ronny Kalash, et al.
Frontiers in Oncology|April 17, 2024
Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot studyAmani Kais, Stell Patadji Santiago, Peng Cheng Han, et al.
Cancer|April 26, 2016
Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomasZachary D Horne, Scott M Glaser, John A Vargo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2018
Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation TherapyBrian J Gebhardt, John A Vargo, Diane Ling, et al.
The Laryngoscope|October 15, 2013
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancerJohn A Vargo, Gregory J Kubicek, Robert L Ferris, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Oral Oncology|September 2, 2014
Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking historyKara S Davis, John A Vargo, Robert L Ferris, et al.
Practical Radiation Oncology|November 5, 2025
A Case for Caution in a New Era of Managing Patients with Locally Advanced Non-Small Cell Lung Cancer: Fatal Bronchial-Esophageal Fistula After Neoadjuvant Chemo-Immunotherapy Followed by Definitive Chemoradiation TherapyKaitlyn Heintzelman, John C Knoth, Casey Mozingo, et al.
Seminars in Radiation Oncology|March 23, 2016
Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell CarcinomaKimmen Quan, Karen M Xu, Yongqian Zhang, et al.
American Journal of Clinical Oncology|April 11, 2017
Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland MalignanciesBrian J Gebhardt, James P Ohr, Robert L Ferris, et al.
Oncoimmunology|May 31, 2019
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRTMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, William E Gooding, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2018
Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic CancerPhilip Sutera, David A Clump, Ronny Kalash, et al.
Frontiers in Oncology|April 17, 2024
Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot studyAmani Kais, Stell Patadji Santiago, Peng Cheng Han, et al.
Cancer|April 26, 2016
Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomasZachary D Horne, Scott M Glaser, John A Vargo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2018
Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation TherapyBrian J Gebhardt, John A Vargo, Diane Ling, et al.
The Laryngoscope|October 15, 2013
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancerJohn A Vargo, Gregory J Kubicek, Robert L Ferris, et al.
Pageof 8